Author(s): Haynes RK, Krishna S
Multidrug-resistant malaria caused by Plasmodium falciparum has severely limited treatment options over recent years. Artemisinins are still effective for treating uncomplicated as well as severe malaria, because resistance is not yet clinically apparent. This article reviews some clinically useful properties of artemisinins and how they might work.
Author(s): Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z
Author(s): Mitscher LA, Drake S, Gollapudi SR, Harris JA, Shankel DM
Author(s): Williams DH, Stone MJ, Hauck PR, Rahman SK
Author(s): James F, Kerwin Jr.
Author(s): White NJ
Author(s): ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S
Author(s): Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group
Author(s): Woodrow CJ, Planche T, Krishna S
Author(s): Toovey S
Author(s): Haynes RK
Author(s): Haynes RK
Author(s): Haynes RK, Ho WY, Chan HW, Fugmann B, Stetter J, et al.
Author(s): Haynes RK
Author(s): Haynes RK, Fugmann B, Stetter J, Rieckmann K, Heilmann HD, et al.
Author(s): Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, et al.
Author(s): Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FC, et al.
Author(s): Wall ME, Wani MC
Author(s): Maureen RA
Author(s): Aicher TD, Buszek KR, Fang FG, Forsyth CJ, Jung SH, et al.
Author(s): Devlin JP
Author(s): Vaschetto M, Weissbrod T, Bodle D, Güner O
